Study in Subjects With Small Primary Choroidal Melanoma
Status:
Completed
Trial end date:
2021-01-26
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety, immunogenicity and efficacy of one of three
dose levels and repeat dose regimens of Light-activated AU-011 and one or two laser
applications for the treatment of subjects with primary choroidal melanoma.